Health Care & Life Sciences » Pharmaceuticals | Shanxi CY Pharmaceutical Group Co. Ltd.

Shanxi CY Pharmaceutical Group Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
506,172.40
644,048.40
674,259.10
734,442.10
924,591.70
1,116
Cost of Goods Sold (COGS) incl. D&A
191,958.90
223,228.60
235,258.90
276,548.40
312,056.10
302
Gross Income
314,213.50
420,819.90
439,000.20
457,893.60
612,535.50
814
SG&A Expense
267,403.80
363,413.30
388,159.10
414,377.20
578,166.20
773
EBIT
45,282.70
53,925.80
46,723.30
47,628.60
34,054.30
40
Unusual Expense
4,130.90
201.40
9,684.50
21,070.60
11,111.90
43
Non Operating Income/Expense
977.10
5,428.80
8,590.80
31,560.40
35,311.60
33
Interest Expense
4,112.40
6,640.30
9,412.00
14,455.00
15,836.50
14
Pretax Income
42,739.30
60,216.80
39,409.80
45,518.10
45,584.70
18
Income Tax
7,664.00
4,325.50
9,289.90
6,700.50
10,379.50
5
Equity in Affiliates
-
-
1,065.10
1,258.00
4,310.70
3
Consolidated Net Income
35,075.30
55,891.30
29,054.80
37,559.60
30,894.50
10
Net Income
27,112.40
40,997.50
22,900.00
30,147.70
21,673.40
7
Net Income After Extraordinaries
27,112.40
40,997.50
22,900.00
30,147.70
21,673.40
7
Net Income Available to Common
27,112.40
40,997.50
22,900.00
30,147.70
21,673.40
7
EPS (Basic)
0.14
0.21
0.12
0.14
0.10
0.03
Basic Shares Outstanding
192,672.00
192,672.00
197,840.40
208,308.00
208,308.00
208
EPS (Diluted)
0.14
0.21
0.12
0.14
0.10
0.03
Diluted Shares Outstanding
192,672.00
192,672.00
197,840.40
208,308.00
208,308.00
208
EBITDA
70,978.00
91,338.80
90,986.90
96,165.30
85,182.80
95
Other Operating Expense
1,527.00
3,480.70
4,117.90
4,112.10
315.00
1
Non-Operating Interest Income
3,778.10
4,370.70
1,367.50
1,854.70
3,167.20
1
Minority Interest Expense
7,962.90
14,893.80
6,154.80
7,411.90
9,221.10
3

About Shanxi CY Pharmaceutical Group Co.

View Profile
Address
53 Hubin Avenue
Datong Shanxi 037010
China
Employees -
Website http://www.cy-pharm.com
Updated 07/08/2019
Shanxi C&Y Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of medicine and healthy food. Its business areas include Medicine, Healthy food, Services, and Commerce. Its products include anti-infective drugs, respiratory medicine, urinary system medicine, child medication, cardiovascular and cerebrovascular drugs, antidepressants, pharmaceutical raw materials and intermediates, and healthy food.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.